mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.001 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.001 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.14 |
0.001 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.002 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.002 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |